Polypharmacy and injurious falls in older adults: a nationwide nested case-control study

References

• Lucas R, Martins A, Severo M, et al. Quantitative modelling of hip fracture trends in 14 European countries: testing variations of a shared reversal over time. Sci Rep. 2017;7(1):3754. doi:10.1038/s41598-017-03847-x28623255
   PubMed Web of Science ®Google Scholar
• Verma SK, Willetts JL, Corns HL, et al. Falls and fall-related injuries among community-dwelling adults in the United States. PLoS One. 2016;11(3):1–14. doi:10.1371/journal.pone.0150939
   Web of Science ®Google Scholar
• Gill TM, Murphy TE, Gahbauer EA, Allore HG. Association of injurious falls with disability outcomes and nursing home admissions in community-living older persons. Am J Epidemiol. 2013;178(3):418–425. doi:10.1093/aje/kws55423548756
   PubMed Web of Science ®Google Scholar
• Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693–698. doi:10.1111/jgs.1530429512120
   PubMed Web of Science ®Google Scholar
• Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology. 2010;21(5):658–668. doi:10.1097/EDE.0b013e3181e8990520585256
   PubMed Web of Science ®Google Scholar
• Ek S, Rizzuto D, Fratiglioni L, Johnell K, Xu W, Welmer AK. Risk profiles for injurious falls in people over 60: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2018;73(2):233–239. doi:10.1093/gerona/glx11528605455
   PubMed Web of Science ®Google Scholar
• Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–1960. doi:10.1001/archinternmed.2009.35719933955
   PubMedGoogle Scholar
• Tinetti ME, Han L, Lee DSH, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–595. doi:10.1001/jamainternmed.2013.1476424567036
   PubMed Web of Science ®Google Scholar
• Johnell K, Jonasdottir Bergman G, Fastbom J, Danielsson B, Borg N, Salmi P. Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults. Int J Geriatr Psychiatry. 2017;32(4):414–420. doi:10.1002/gps.448327113813
   PubMed Web of Science ®Google Scholar
• Seppala LJ, Wermelink AMAT, de Vries M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11–371.e17. doi:10.1016/j.jamda.2017.12.098
   Web of Science ®Google Scholar
• Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–2272. doi:10.1111/jgs.1315325516023
   PubMed Web of Science ®Google Scholar
• Dhalwani NN, Fahami R, Sathanapally H, Seidu S, Davies MJ, Khunti K. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017;7(10):1–8. doi:10.1136/bmjopen-2017-016358
   Web of Science ®Google Scholar
• Laflamme L, Monárrez-Espino J, Johnell K, Elling B, Möller J, Icks A. Type, number or both? A population-based matched case-control study on the risk of fall injuries among older people and number of medications beyond fall-inducing drugs. PLoS One. 2015;10(3):e0123390. doi:10.1371/journal.pone.012339025815483
   PubMed Web of Science ®Google Scholar
• Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012;12(3):425–430. doi:10.1111/j.1447-0594.2011.00783.x22212467
   PubMed Web of Science ®Google Scholar
• Bergland A, Jarnlo GB, Laake K. Predictors of falls in the elderly by location. Aging Clin Exp Res. 2003;15(1):43–50.12841418
   PubMed Web of Science ®Google Scholar
• Clough-Gorr KM, Erpen T, Gillmann G, et al. Preclinical disability as a risk factor for falls in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2008;63(3):314–320. doi:10.1093/gerona/63.3.31418375881
   PubMed Web of Science ®Google Scholar
• Pluijm SMF, Smit JH, Tromp EAM, et al. A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling: results of a 3-year prospective study. Osteoporos Int. 2006;17(3):417–425. doi:10.1007/s00198-005-0002-016416256
   PubMed Web of Science ®Google Scholar
• Bennett A, Gnjidic D, Gillett M, et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014;31(3):225–232. doi:10.1007/s40266-013-0151-324452921
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753–758. doi:10.1002/pds.362424723335
   PubMed Web of Science ®Google Scholar
• Langeard A, Pothier K, Morello R, et al. Polypharmacy cut-off for gait and cognitive impairments. Front Pharmacol. 2016;7:296. doi:10.3389/fphar.2016.0032327630572
   PubMed Web of Science ®Google Scholar
• George C, Verghese J. Polypharmacy and gait performance in community–dwelling older adults. J Am Geriatr Soc. 2017;65(9):2082–2087. doi:10.1111/jgs.1495728649786
   PubMed Web of Science ®Google Scholar
• Rawle MJ, Cooper R, Kuh D, Richards M. Associations between polypharmacy and cognitive and physical capability: a british birth cohort study. J Am Geriatr Soc. 2018 Epub. doi:10.1111/jgs.15317
   Web of Science ®Google Scholar
• Morin L, Johnell K, Laroche M-L, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–298. doi:10.2147/CLEP.S15345829559811
   PubMed Web of Science ®Google Scholar
• Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-Risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc. 2018;19(4):372.e1–372.e8. doi:10.1016/j.jamda.2017.12.099
   Web of Science ®Google Scholar
• Jokanovic N, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1–535.e12. doi:10.1016/j.jamda.2015.03.003
   Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667. doi:10.1007/s10654-009-9350-y19504049
   PubMed Web of Science ®Google Scholar
• Bergström MF, Byberg L, Melhus H, Michaelsson K, Gedeborg R. Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev. 2011;17(2):108–113. doi:10.1136/ip.2010.02895121113015
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi:10.1002/pds.129416897791
   PubMed Web of Science ®Google Scholar
• Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209–220. doi:10.1111/bcp.1261725735839
   PubMed Web of Science ®Google Scholar
• Calderón-Larrañaga A, Vetrano DL, Onder G, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol A Biol Sci Med Sci. 2017;72(10):1417–1423.28003375
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie R. A new method of classifying prognostic in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.3558716
   PubMedGoogle Scholar
• Bell JS, Johnell K, Wimmer BC, Wiese MD. Multidose drug dispensing and optimising drug use in older people. Age Ageing. 2013;42(5):556–558. doi:10.1093/ageing/aft08023877995
   PubMed Web of Science ®Google Scholar
• Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700 000 elderly. Scand J Prim Health Care. 2008;26(2):86–91. doi:10.1080/0281343080202219618570006
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Education of the Population. Örebro: Statistics Sweden (SCB); 2014.
   Google Scholar
• Hosmer DW, Lemeshowr S, Sturdivantr RX. Logistic Regression for Matched Case-Control Studies. In: Hosmer DW, Lemeshowr S, Sturdivantr RX. Applied Logistic Regression. Hoboken, New Jersey: Wiley; 2013:243–268.
   Google Scholar
• Pearce N. Analysis of matched case-control studies. BMJ. 2016;352:i969. doi:10.1136/bmj.i171726916049
   PubMed Web of Science ®Google Scholar
• Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol. 2008;168(9):1073–1081. doi:10.1093/aje/kwn21718794220
   PubMed Web of Science ®Google Scholar
• Mansournia MA, Altman DG. Population attributable fraction. BMJ. 2018;k757. doi:10.1136/bmj.k75729472187
   PubMed Web of Science ®Google Scholar
• Coughlin SS, Benichou J, Weed DL. Attributable risk estimation in case-control studies. Epidemiol Rev. 1994;16(1):51–64. doi:10.1093/oxfordjournals.epirev.a0361447925727
   PubMed Web of Science ®Google Scholar
• Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25(4):242–244. doi:10.1136/jech.25.4.2425160433
   PubMedGoogle Scholar
• Newton HJ, Baum CF, Beck N, et al. Attributable and unattributable risks and fractions and other scenario comparisons. Stata J. 2013;13(4):672–698. doi:10.1177/1536867X1301300402
   Web of Science ®Google Scholar
• Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ;2018:k3532. doi:10.1136/bmj.k353230429167
   PubMed Web of Science ®Google Scholar
• Bradford-Hill A. The Enviroment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.14283879
   PubMedGoogle Scholar
• Wastesson JW, Morin L, Laroche M-L, Johnell K. How chronic is polypharmacy in old age? A longitudinal nationwide cohort study. J Am Geriatr Soc. 2019;67(3):455–462. doi:10.1111/jgs.1571730575952
   PubMed Web of Science ®Google Scholar
• Schlesinger A, Weiss A, Nenaydenko O, Adunsky A, Beloosesky Y. Does polypharmacy in nursing homes affect long-term mortality? J Am Geriatr Soc. 2016;64(7):1432–1438. doi:10.1111/jgs.1421327304579
   PubMed Web of Science ®Google Scholar
• Veronese N, Stubbs B, Noale M, et al. Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc. 2017;18(7):624–628. doi:10.1016/j.jamda.2017.02.00928396180
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995. doi:10.1016/j.jclinepi.2012.02.01822742913
   PubMed Web of Science ®Google Scholar
• Wise J. Polypharmacy: a necessary evil. BMJ. 2013;347:f7033–f7033. doi:10.1136/bmj.f703324286985
   PubMed Web of Science ®Google Scholar
• Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation. Making it safe and sound. London: The King's Fund; 2013:1–68. Available from https://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-optimisation
   Google Scholar
• Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. Br Med J. 2015;350(jan20 2):h176–h176. doi:10.1136/bmj.h17625646760
   PubMed Web of Science ®Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2018;9:CD008165. doi:10.1002/14651858.CD008165.pub4
   Google Scholar
• Salisbury C, Man M, Bower P, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. Lancet. 2018;6736(18):1–10.
   Google Scholar
• Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;2(CD007146):CD007146.
   Google Scholar
• Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018. doi:10.1016/j.jamda.2018.06.021
   Web of Science ®Google Scholar
• Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017;12(4). doi:10.1371/journal.pone.0174730
   Web of Science ®Google Scholar
• Treves N, Perlman A, Geron LK, Asaly A, Matok I. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018;47(2):201–208. doi:10.1093/ageing/afx16729077902
   PubMed Web of Science ®Google Scholar
• de Souto-Barreto P, Rolland Y, Vellas B, Maltais M. Association of long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults. A systematic review and meta-analysis. JAMA Intern Med 2019;179(3):394–405. doi:10.1001/jamainternmed.2018.540
   Google Scholar
• Sinnott S-J, Polinski JM, Byrne S, Gagne JJ. Measuring drug exposure: concordance between defined daily dose and days’ supply depended on drug class. J Clin Epidemiol. 2016;69:107–113. doi:10.1016/j.jclinepi.2015.05.02626146090
   PubMed Web of Science ®Google Scholar
• Gamble J-M, McAlister FA, Johnson JA, Eurich DT. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study. Value Heal. 2012;15(1):191–197. doi:10.1016/j.jval.2011.08.005
   Web of Science ®Google Scholar
• Horwitz RI, Feinstein AR. The problem of “protopathic bias” in case-control studies. Am J Med. 1980;68(2):255–258.7355896
   PubMed Web of Science ®Google Scholar
• Welmer AK, Rizzuto D, Laukka EJ, Johnell K, Fratiglioni L. Cognitive and physical function in relation to the risk of injurious falls in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2017;72(5):669–675.27449140
   PubMed Web of Science ®Google Scholar